Predictors of clonidine response in Tourette syndrome: Implications and inferences

Journal of Child Neurology

Volumn 11, Issue 2, 1996, Pages 93-97

  Lichter, David G ^a   Jackson, Lisa A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIASTOLIC BLOOD PRESSURE; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL BRAIN DYSFUNCTION; NORADRENERGIC SYSTEM; OBSESSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029913192     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389601100205     Document Type: Article

References (45)

1. Kurlan R: Tourette's syndrome: Current concepts. Neurology 1989;39:1625-1630.
2. Comings DE, Comings BG: Tourette syndrome and attention deficit disorder with hyperactivity: Are they genetically related? J Am Acad Child Psychiatry 1984;23:138-146.
3. Comings DE, Comings BG: A controlled study of Tourette syndrome. I. Attention deficit disorder, learning disorders and school problems. Am J Hum Genet 1987;41:701-741.
4. Singer HS, Walkup JT: Tourette syndrome and other tic disorders: Diagnosis, pathophysiology, and treatment. Medicine 1991;70:15-32.
5. Cohen DJ, Leckman JF: Developmental psychopathology and neurobiology of Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1994;33:2-15.
6. Pauls DL, Leckman JF, Cohen DJ: Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry 1993;32:1044-1050.
7. Towbin KE, Cohen DJ, Leckman JF: Tic disorders, in Karasu TB (ed): Treatments of Psychiatric Disorders. Washington, DC, American Psychiatric Association, 1989, pp 687-714.
8. Cohen DJ, Young JG, Nathanson JA, Shaywitz BA: Clonidine in Tourette's syndrome. Lancet 1979;2:551-553.
9. Stefl MD: The Ohio Tourette Study: An Investigation of the Special Service Needs of Tourette Syndrome Patients. Cincinnati, Tourette Syndrome Association of Ohio, 1983, p 31.
10. Leckman JF, Hardin MT, Riddle MA, et al: Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1991; 48:324-328.
11. Leckman JF, Cohen JC, Detlor J, et al: Clonidine in the treatment of Tourette syndrome: A review of data. Adv Neurol 1982; 35:391-401.
12. Jagger J, Prusoff BA, Cohen DJ, et al: The epidemiology of Tourette's syndrome: A pilot study. Schizophr Bull 1982;8: 267-278.
13. Leckman JF, Cohen DJ, Price RA, et al: The pathogenesis of Tourette syndrome: A review of data and hypotheses, in Shah NS, Donald AG (eds): Movement Disorders. New York, Plenum, 1986, pp 257-272.
14. Goetz CG: Clonidine and clonazepam in Tourette syndrome. Adv Neurol 1992;58:245-251.
15. Leckman JF, Walkup JT, Cohen DJ: Clonidine treatment of Tourette's syndrome, in Cohen DJ, Bruun RD, Leckman JF (eds): Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, John Wiley, 1988, pp 291-301.
16. Leckman JF, Riddle MA, Hardin MT, et al: The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566-573.
17. Leckman JF, Towbin KE, Ort SI, Cohen DJ: Clinical assessment of tic disorder severity, in Cohen DJ, Bruun RD, Leckman JF (eds): Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, John Wiley, 1988, pp 55-78.
18. Shapiro AK, Shapiro ES, Young JG, Feinberg TE: Gilles de la Tourette Syndrome, 2nd ed. New York, Raven Press, 1988, p 510.
19. Hunt RD, Minderaa RB, Cohen DJ: Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry 1985;24:617-629.
20. Hunt RD, Minderaa RB, Cohen DJ: The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: A comparison with placebo and methylphenidate. Psychopharmacol Bull 1986;22:229-236.
21. Steingard R, Biederman J, Spencer T, et al: Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 1993;32:350-353.
22. Cohen DJ, Riddle MA, Leckman JF: Pharmacotherapy of Tourette's syndrome and associated disorders. Psychiatr Clin North Am 1992;15:109-129.
23. Steingard RJ, Goldberg M, Lee D, DeMaso DR: Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD. J Am Acad Child Adolesc Psychiatry 1994;33:394-399.
24. Leckman JF, Cohen DJ: Descriptive and diagnostic classification of tic disorders, in Cohen DJ, Bruun RD, Leckman JF (eds): Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, John Wiley, 1988, pp 3-19.
25. Bruun RD: The natural history of Tourette's syndrome, in Cohen DJ, Bruun RD, Leckman JF (eds): Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, John Wiley, 1988, pp 21-39.
26. Svensson TH, Bunney BS, Aghajanian GK: Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res 1975;92:291-306.
27. Grenhoff J, Svensson TH: Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur J Pharmacol 1989;165: 11-18.
28. Geyer MA, Lee EHY: Effects of clonidine, piperoxane and locus coeruleus lesion on the serotonergic and dopaminergic systems in raphe and caudate nucleus. Biochem Pharmacol 1984;33: 3399-3404.
29. Zametikin AJ, Rapoport JL: Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 1987;26:676-686.
30. Levy F, Hobbes G: The action of stimulant medication in attention deficit disorder with hyperactivity: Dopaminergic, noradrenergic, or both? J Am Acad Child Adolesc Psychiatry 1988; 27:802-805.
31. Leckman JF, Riddle MA, Cohen DJ: Pathobiology of Tourette's syndrome, in Cohen DJ, Bruun RD, Leckman JF (eds): Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, John Wiley, 1988, pp 103-116.
32. Young JG, Cohen DJ, Hattox SE, et al: Plasma free MHPG and neuroendocrine responses to challenge doses of clonidine in Tourette's syndrome: Preliminary report. Life Sci 1981;29: 1467-1475.
33. Garfinkel BD, Wender P, Sloman L, O'Neill I: Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. J Am Acad Child Psychiatry 1983;22:343-348.
34. Rapoport J, Quinn PO, Bradbard G, et al: Imipramine and methylphenidate treatments of hyperactive boys. Arch Gen Psychiatry 1974;30:789-793.
35. Fredrikson M, Mathews KA: Cardiovascular responses to behavioral stress and hypertension: A meta-analytic review. Ann Behav Med 1990;12:30-39.
36. Lamprecht F, Eichelman B, Thoa NB, et al: Rat fighting behavior: Serum dopamine-beta-hydroxylase and hypothalamic tyrosine hydroxylase. Science 1972;177:1214-1215.
37. Lake CR, Ziegler MG, Murphy DL: Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry 1977;34:533-536.
38. Cohen DJ, Johnson WT: Cardiovascular correlates of attention in normal and psychiatrically disturbed children: Blood pressure, peripheral blood flow and peripheral vascular resistance. Arch Gen Psychiatry 1977;34:561-567.
39. Frankhauser MP, Karumanchi VC, German ML, et al: A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 1992;53:77-82.
40. Koslow SH, Cross CK: Cerebrospinal fluid monoamine metabolites in Tourette syndrome and their neuroendocrine implications. Adv Neurol 1982;35:185-197.
41. Singer HS, Butler IJ, Tune LE, et al: Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 1982;12:361-366.
42. Leckman JF, Ort L, Cohen DJ, et al: Rebound phenomenon in Tourette's syndrome after abrupt withdrawal of clonidine: Behavioral, cardiovascular and neurochemical effects. Arch Gen Psychiatry 1986;43:1168-1176.
43. Leckman JF, Pauls DL, Peterson BS, et al: Pathogenesis of Tourette's syndrome: Clues from the clinical phenotype and natural history. Adv Neurol 1992;58:15-23.
44. Erenberg G, Cruse RP, Rothner AD: Gilles de la Tourette's syndrome: Effects of stimulant drugs. Neurology 1985;35:1346-1348.
45. Sverd J, Gadow KD, Paolicelli LM: Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette syndrome. J Am Acad Child Adolesc Psychiatry 1989;28:574-579.